Marla C. Dubinsky

35.5k citations

459 papers · 12.2k indexed · 6 hit papers · h-index 57

Impact in

Genetics top 0.05%
- Inflammatory Bowel Disease
Gastroenterology top 0.5%

Papers in

Genetics 351
- Inflammatory Bowel Disease 350
Gastroenterology 47

Co-authors: Stephan R. Targan María T. Abreu Eric A. Vasiliauskas Dermot McGovern Phillip Fleshner Sunanda V. Kane Corey A. Siegel William J. Sandborn
Journals: Inflammatory Bowel Diseases (86 papers)Gastroenterology (70 papers)Journal of Crohn s and Colitis (64 papers)The American Journal of Gastroenterology (61 papers)Clinical Gastroenterology and Hepatology (18 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

Marla C. Dubinsky

421 papers receiving 11.9k citations

Hit Papers

6 papers align trajectories log scale

Understanding the therapeutic toolkit for inflammatory bowel disease 2025 · 35 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2025 Nature Reviews Gastroenterology & Hepatology
2023 The Lancet
2023 New England Journal of Medicine
2019 Gastroenterology
2014 Nature Genetics
2012 Science

Peers

Countries citing papers authored by Marla C. Dubinsky

Since Specialization

Citations

This map shows the geographic impact of Marla C. Dubinsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marla C. Dubinsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marla C. Dubinsky more than expected).

Fields of papers citing papers by Marla C. Dubinsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marla C. Dubinsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marla C. Dubinsky. The network helps show where Marla C. Dubinsky may publish in the future.

Co-authors

The 25 scholars most cited alongside Marla C. Dubinsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marla C. Dubinsky Line = papers co-authored together Marla C. Dubinsky links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Disease duration impacts intestinal gene expression profiles in Crohn’s disease but not in ulcerative colitis Journal of Crohn s and Colitis ·Annette L. Varcoe, Jiaobao Song, Bernhard Y. Renard, Louis Cohen, Carmen Argmann, Drew Helmus, Eric E. Schadt, Miriam Mérad, A. K. Kukreja, Sudha Visvanathan, Bruce E. Sands, Marla C. Dubinsky, Mayte Suárez‐Fariñas, Jean‐Frédéric Colombel, Erwin P. Böttinger, Judy H. Cho, Francesca Petralia, Ryan C. Ungaro	2025	0
2	Ustekinumab Drug Clearance Is Better Associated with Disease Control than Serum Trough Concentrations in a Prospective Cohort of Inflammatory Bowel Disease Pharmaceutics ·Andrés Yarur, Thierry Dervieux, Ryan C. Ungaro, Elizabeth A. Spencer, Jim Mann, Lizbeth Núñez, Piotr Graff, Séverine Vermeire, Zhigang Wang, John C. Panetta, Erwin Dreesen, Marla C. Dubinsky	2025	0
3	Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease The American Journal of Gastroenterology ·Uma Mahadevan, Cynthia H. Seow, Edward L. Barnes, María Chaparro, Emma Flanagan, Sonia Friedman, Mette Julsgaard, Sunanda V. Kane, Siew C. Ng, Joana Torres, Gillian Watermeyer, Jesús K. Yamamoto‐Furusho, Christopher Robinson, 友紀藤山, Phil Anderson, Richard B. Gearry, Dana Ďuricová, Marla C. Dubinsky, Paola Estrada Azarte, (unknown)	2025	2
4	P720 Exit interviews exploring Crohn’s disease patients’ experience of changes in their bowel urgency during the mirikizumab Phase 3 clinical trial in adult patients with moderate to severe Crohn disease Journal of Crohn s and Colitis ·(unknown), Jake Macey, H.L.J. Makin, Mohammad Hafiz Mohd Zaki, Katie Mellor, Helen Kitchen, Hilde Carlier, Marla C. Dubinsky	2024	3
5	DOP18 Efficacy of risankizumab versus ustekinumab by baseline Crohn’s Disease location: post-hoc analysis of the SEQUENCE head-to-head trial Journal of Crohn s and Colitis ·Laurent Peyrin‐Biroulet, J F Colombel, Geert D’Haens, Marla C. Dubinsky, Qian Cao, Kristina Kligys, J. Gati, Alba Virtud Contreras Marín, Ezequiel Neimark, Shenyun Shi, Jeffrey Crowley, Remo Panaccione	2024	2
6	INCREASING ACCESS TO INTERDISCIPLINARY IBD CARE FOR NEWLY DIAGNOSED IBD PATIENTS USING TELEMEDICINE: AN EXTENSION OF THE COMPASS-IBD PROGRAM Inflammatory Bowel Diseases ·Marc Mason, H Holzworth Robert, Sepdian Luri Asmono, رنا هشام عبد الستار, T. Thordarson, X. Chen, 明子檜山, BRUNA DE JESUS SOUZA, Marla C. Dubinsky, Laurie Keefer, Ryan C. Ungaro	2024	0
7	P407 Efficacy and safety of etrasimod in subjects with moderately to severely active isolated proctitis: a subgroup analysis of the phase 3 ELEVATE UC 52 and ELEVATE UC 12 trials Journal of Crohn s and Colitis ·Laurent Peyrin‐Biroulet, Marla C. Dubinsky, B E Sands, Julián Panés, S Schreiber, Walter Reinisch, B G Feagan, Silvio Danese, Andrés Yarur, Geert D’Haens, Lamia Al-Hourani, K. Kovats, Joseph Wu, Irene Modesto, M Sekunda, Sonika Choudhary, Hemal H. Parekh, Séverine Vermeire	2023	4
8	DOP87 The Anti-TL1A Antibody PRA023 Demonstrated Proof-of-Concept in Crohn’s Disease: Phase 2a APOLLO-CD Study Results Journal of Crohn s and Colitis ·B G Feagan, B E Sands, Corey A. Siegel, Marla C. Dubinsky, Terence Driscoll, Annisa Sofyarani Supriatno, J. E. Scardefield, Allison Luo, N. Synyavska, Haotian Xia, 伊藤勝彦, Martina Nylander, 上別府圭子, Kalle Lenti, Barroso Aké	2023	22
9	P476 Characterization of cardiac conduction abnormalities reported in the phase 3 ELEVATE programme Journal of Crohn s and Colitis ·Séverine Vermeire, Andrés Yarur, David T. Rubin, Marla C. Dubinsky, Miguel Regueiro, Peter M. Irving, Laurent Peyrin‐Biroulet, Lamia Al-Hourani, Amit Vasant Kulkarni, Joseph Wu, Irene Modesto, M Sekunda, Hemal H. Parekh, T. Calderwood, J Mellan	2023	3
10	P632 Etrasimod induction therapy in moderately to severely active Crohn’s disease: results from a phase 2, randomised, double-blind substudy Journal of Crohn s and Colitis ·Geert D’Haens, Marla C. Dubinsky, Laurent Peyrin‐Biroulet, Silvio Danese, B E Sands, Douglas C. Wolf, Andrés Yarur, Michael Chiorean, Juan Pablo Sanabria Villate, Irene Modesto, Huaming Tan, Amit Vasant Kulkarni, P. Boelhouwer, Chunyan Su, Tai Pang Wu, Fabio Cataldi, M Sekunda, Stefanie Schreiber, B G Feagan, Séverine Vermeire	2023	14
11	Acute Severe Ulcerative Colitis Is Associated With an Increased Risk of Acute Pouchitis Inflammatory Bowel Diseases ·Maia Kayal, M Vea, Angelita de Almeida Oliveira Lima, Barbora Kyas, Sergey Khaitov, Patricia Sylla, Alexander J. Greenstein, Marla C. Dubinsky, Saurabh Mehandru, Jean‐Frédéric Colombel	2023	12
12	DOP38 Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1 Journal of Crohn s and Colitis ·Séverine Vermeire, J F Colombel, Ken Takeuchi, Xiang Gao, Remo Panaccione, Silvio Danese, Marla C. Dubinsky, Stefan Schreiber, Dapo Ilo, Tricia Finney‐Hayward, Wen Zhou, Charles M. Phillips, Xuan Yao, Qian Zhou, Edward V. Loftus	2022	10
13	Early Pouchitis Is Associated With Crohn’s Disease–like Pouch Inflammation in Patients With Ulcerative Colitis Inflammatory Bowel Diseases ·Maia Kayal, David Köhler, Barbora Kyas, Sergey Khaitov, Patricia Sylla, Alexander J. Greenstein, Marla C. Dubinsky	2022	10
14	Tu1866 EFFICACY AND SAFETY OF AN ADDITIONAL 8 WEEKS OF TOFACITINIB INDUCTION THERAPY: UPDATED RESULTS OF THE OCTAVE OPEN STUDY FOR TOFACITINIB 8-WEEK INDUCTION NON-RESPONDERS Gastroenterology ·David T. Rubin, Marla C. Dubinsky, Silvio Danese, Rogério Saad-Hossne, Darío Ponce de León, Eric S. Maller, Nervin Lawendy, Kenneth Kwok, Chinyu Su	2020	1
15	Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease Alimentary Pharmacology & Therapeutics ·Uma Mahadevan, Séverine Vermeire, Karen Lasch, M.T. Ir. Sofiyah, Fatima Bhayat, Aimee Blake, Marla C. Dubinsky	2017	78
16	P735. Exploring mechanisms of inflammatory bowel disease transmission in utero through the microbiome: the MECONIUM Study Pilot Journal of Crohn s and Colitis ·Argelia Idalia Cortés Cervantes, Jianzhong Hu, Justin Côté-Daigneault, Hina Panchal, Caroline Eisele, Xiuliang Bao, J. Graftiau, Cheng‐Lun Chen, Marla C. Dubinsky, James George, Asher Kornbluth, Peter Legnani, James F. Marion, Elana Maser, Thomas Ullman, Bindia Jharap, James L. Stone, José C. Clemente, Jean‐Frédéric Colombel, Inga Peter	2016	1
17	P565. The Increased Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients is not Related To Inflammatory Load Journal of Crohn s and Colitis ·Yusuf Erzın, Nurhan Demir, Mehmat Sinan Bilgili, Fatih Kantarcı, İbrahim Hatemı, Aykut Ferhat Çelık, Vijay Yajnik, Nabeel Khan, Marla C. Dubinsky, Jeffrey Axler, Adèle C. Green, M.T. Ir. Sofiyah, Karen Lasch	2015	3
18	P566. Efficacy and safety of vedolizumab with advancing age in patients with ulcerative colitis: Results from the GEMINI 1 study Journal of Crohn s and Colitis ·Yusuf Erzın, Nurhan Demir, Mehmat Sinan Bilgili, Fatih Kantarcı, İbrahim Hatemı, Aykut Ferhat Çelık, Vijay Yajnik, Nabeel Khan, Marla C. Dubinsky, Jeffrey Axler, Adèle C. Green, M.T. Ir. Sofiyah, Karen Lasch, (unknown)	2015	1
19	Randomised clinical trial: individualised vs. weight‐based dosing of azathioprine in Crohn's disease Alimentary Pharmacology & Therapeutics ·А. И. Гордиюк, Marla C. Dubinsky, B. Novitt, Gerardo Ouiroga‐Goode, Joseph A. Galanko, C. Bauer, Robert S. Sandler, 重人濱口	2013	60
20	Interactions Between Commensal Fungi and the C-Type Lectin Receptor Dectin-1 Influence Colitis Science ·Iliyan D. Iliev, Vincent Funari, Kent D. Taylor, Quoclinh Nguyen, Christopher N. Reyes, Samuel P. Strom, Jordan Brown, Courtney Becker, Phillip Fleshner, Marla C. Dubinsky, Jerome I. Rotter, Hanlin L. Wang, Dermot McGovern, Gordon D. Brown, David M. Underhill Hit paper breakdown →	2012	827

About Marla C. Dubinsky

Marla C. Dubinsky is a scholar working on Genetics, Gastroenterology, Epidemiology, Immunology and Speech and Hearing, having authored 459 papers that have together received 12.2k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (350 papers), Microscopic Colitis (211 papers), Eosinophilic Esophagitis (74 papers), Pregnancy and Medication Impact (61 papers), Immunodeficiency and Autoimmune Disorders (49 papers), Helicobacter pylori-related gastroenterology studies (38 papers), Adolescent and Pediatric Healthcare (33 papers) and Autoimmune and Inflammatory Disorders (31 papers). The work is most often cited by research in Genetics (7.1k citations), Gastroenterology (916 citations), Epidemiology (5.1k citations), Immunology (2.9k citations) and Public Health, Environmental and Occupational Health (3.1k citations). Marla C. Dubinsky has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Stephan R. Targan, María T. Abreu, Eric A. Vasiliauskas, Dermot McGovern, Phillip Fleshner, Sunanda V. Kane, Corey A. Siegel, William J. Sandborn, Gil Melmed and Uma Mahadevan. Their work appears in journals such as Inflammatory Bowel Diseases, Gastroenterology, Journal of Crohn s and Colitis, The American Journal of Gastroenterology and Clinical Gastroenterology and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact